RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Bellaire, TX · League City, TX · Red Oak, TX · +22 more sites